Helping Drug Companies Demonstrate Real World Value

Through Outcomes Research

SCHEDULE a  DISCOVERY CALL
ABOUT US

SOARING HEALTH partners with pharmaceutical, biotech, and life sciences organizations to generate meaningful evidence, strengthen market access strategy, and translate data into decisions that improve patient, payer, and business outcomes.

We help life sciences organizations answer high-value questions about treatment effectiveness, economic value, patient outcomes, and real-world performance. From evidence planning to payer-focused value communication, SOARING HEALTH provides focused consulting support designed for today’s healthcare decision environment.

Why Clients Choose SOARING HEALTH

  • Our work is informed by a strong healthcare and outcomes lens, helping clients connect evidence generation with real patient and system realities.
  • We focus on decision-relevant evidence that can support clinical development, payer engagement, internal planning, and value communication.
  • We emphasize evidence that reflects what happens in practice, where access, adherence, comorbidity, and patient context shape outcomes.
SOARING HEALTH

A Strategic HEOR Partner for Evidence, Access, and Impact

SOARING HEALTH

Real World Evidence

Retrospective studies, claims and EHR analysis, treatment pattern research, adherence evaluation, and comparative effectiveness insights that show how therapies perform outside controlled settings.

Health Economics & Outcomes Research

Cost-effectiveness models, budget impact analyses, burden of illness studies, and economic value communication designed to support reimbursement and access decisions. Patient-centered outcomes, endpoint strategy, evidence synthesis, literature reviews, and research design support that connects treatment use to meaningful outcomes.

SOARING HEALTH

Market Access

Evidence strategy, payer value messaging, dossier support, and communication tools that help stakeholders understand product value more clearly.

OUR SERVICES

Need support for an evidence question, value strategy, or outcomes-focused project?